Browse by topic: All · Fraud and abuse compliance · Investigations · Medicare and Medicaid · Information blocking · Whistleblowers · Other topics
Investigations
- Investigations
HHS OIG’s Spring 2026 Semiannual Report: What Health Care Organizations Should Take Away
For the six-month reporting period ending on March 31, 2026, OIG reported $5.56 billion in total monetary impact, including $4.3 billion in investigative receivables, $814.1 million in audit and evaluation receivables, and $447.6 million in identified potential cost savings. OIG also reported 317 criminal actions, 287 civil actions, and 1,212 program exclusions. The agency stated that it returned $12.70 to the federal government for every dollar of funding received.
- Investigations
DOJ’s New Health Care Fraud Enforcement Playbook Is Data-Driven, Coordinated, and Moving Fast
The DOJ’s latest healthcare fraud enforcement initiatives—including the FOCUS initiative, new strike forces, and updated voluntary disclosure incentives—signal increased scrutiny for providers, startups, and healthcare companies.
- Investigations
When Life Sciences Marketing Practices Require Investigation: Off-Label Promotion, HCP Arrangements, and Anti-Kickback Risk
Most promotional issues do not begin as obvious compliance failures. They often surface through a sales deck, a field communication, a speaker program, a consulting arrangement, a discounting strategy, or questions about how medical affairs is interacting with healthcare professionals. At the outset, the issue may appear to be a routine marketing or training concern. Over time, however, the surrounding facts can change the analysis.
- Investigations
When Financial Relationships Require Investigation: Stark Law and Anti-Kickback Risks in Healthcare
Financial relationships in healthcare operate under a level of regulatory scrutiny that few other industries encounter. Compensation arrangements, consulting agreements, medical directorships, and referral-related relationships routinely involve overlapping operational, business, and legal considerations.
- Investigations
Initial Assessment vs. Full Investigation: How to Respond to Compliance Concerns
When a compliance concern surfaces, the immediate question is usually straightforward: what do we do next? What is less clear is how much to do. Some organizations move quickly into a full investigation, while others take a more informal approach and wait to see how the issue develops. Both approaches can create problems.
- Investigations
Common Mistakes Healthcare and Life Sciences Companies Make During Internal Investigations
When a concern surfaces, organizations are often balancing competing priorities. They want to understand what happened, minimize disruption, and avoid escalating the issue unnecessarily. Those instincts are reasonable. But they can also lead to decisions that make the situation more difficult to manage over time.






